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This study describes an efficient transformation system for the introduction of
plasmid DNA into Bifidobacterium bifidum PRL2010 and Bifidobacterium
asteroides PRL2011, for which to the best of our knowledge no transformation
data have been reported previously. The method is based on electroporation of
bifidobacterial cells, which were made competent by an optimized methodology
based on varying media and growth conditions. Furthermore, the transforma-
tion protocol was applied in order to design a PRL2010-derivative, which car-
ries antibiotic resistance against chloramphenicol and which was used to
monitor PRL2010 colonization in a murine model.
Introduction
Bifidobacteria are Gram-positive G+C%-rich, anaerobic/
microaerophilic, fermentative bacteria, which are often
Y- or V-shaped (Ventura et al., 2007). Bifidobacterium
represents one of the most numerically abundant bacterial
genera of the human gut microbiota in infants and is
presumed to play a fundamental role in host health,
which drives their wide-spread use as probiotic bacteria
in many functional foods. This commercial exploitation
of probiotic bifidobacterial strains has fuelled scientific
interest in these bacteria to identify the genomic traits
that are responsible for the claimed beneficial activities.
To exploit the full potential of these microorganisms for
applications as probiotic ingredients, further knowledge is
required on their molecular biology and genetics. However,
molecular studies of Bifidobacterium are severely hampered
by the absence of effective genetic tools, including efficient
transformation protocols. So far, several Bifidobacterium
strains, including members of Bifidobacterium bifidum
and Bifidobacterium asteroides, have been shown to be non-
transformable or very poorly transformable (Argnani et al.,
1996). Many factors may contribute to bifidobacterial
recalcitrance for acquiring exogenous DNA, such as the
presence of a thick (multilayered) and complex cell wall
(Fischer et al., 1987), intracellular restriction/modification
barriers (Hartke et al., 1996; Schell et al., 2002; O’Connell
Motherway et al., 2009), and sensitivity to environmental
stresses, in particular oxygen, to which these strictly anaer-
obic bacteria are exposed to during the preparation of
competent cells and transformation procedure.
With the advent of the genomics era, many bifidobac-
terial genomes have been fully decoded (for reviews, see
Turroni et al., 2011; Ventura et al., 2009), which has thus
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provided a huge amount of genetic data that can be
exploited to study genome functionality. Such studies are
needed to understand the molecular mechanisms sustain-
ing the interaction of bifidobacteria with its host as well
as with other members of the gut microbiota (Hartke
et al., 1996; Schell et al., 2002; Sela et al., 2008; Ventura
et al., 2009; Turroni et al., 2011).
However, to perform such functional genomic investiga-
tions, it will be necessary to develop transformation proto-
cols as well as to implement gene knock-out methodologies
effective for bifidobacteria. In this report, we describe the
development of a protocol for efficient and reproducible
genetic transformation of B. bifidum PRL2010 by electro-
poration using the shuttle vector pNZ8048 (de Ruyter
et al., 1996). The protocol of transformation is based on
the preparation of electro-competent cells and subsequent
electroporation and on the optimization of several
parameters such as growth conditions, washing solutions,
and electroporation voltage.
Materials and methods
Bacterial strains and plasmids
The Bifidobacterium strains used are described in Table 1.
Plasmid pNZ8048 is a broad-host shuttle vector, which
possesses the nisin-inducible nisA promoter and a chl-
oramphenicol resistance gene as the selection marker (de
Ruyter et al., 1996).
Media and growth conditions
Escherichia coli strain DH10B, used as host strain for
propagating the shuttle vector, was cultivated in LB med-
ium (Savino et al., 2011) supplemented with chloramphe-
nicol (Sigma) at a final concentration of 10 lg mL1.
The susceptibility to chloramphenicol of the bifidobacterial
strains PRL2010 and PRL2011 was tested by means of a
Minimal Inhibitor Concentration (MIC) assay, according
to a previously described procedure (Serafini et al., 2011).
Bifidobacteria were cultivated in de Man–Rogosa–Sharpe
(MRS) medium supplemented with 0.05% cysteine-HCl
(cMRS) in an anaerobic chamber (Concept 400, Ruskin;
2.99% H2, 17.01% CO2 and 80% N2) at 37 °C for
24–72 h. In case of cultivation of bifidobacterial transfor-
mants, chloramphenicol was added to the growth med-
ium cMRS agar at a final concentration of 3 lg mL1.
DNA isolation procedures
Plasmid DNA was isolated from E. coli as well as from
bifidobacterial transformants using a Qiagen Plasmid
Mini Kit. For Bifidobacteria, an additional incubation
step in 20 mg mL1 lysozyme at 37 °C for 40 min was
performed before beginning the Qiagen kit protocol
(Guglielmetti et al., 2008).
Preparation of bacteria for electroporation
An overnight culture of Bifidobacterium (10%) was used
to inoculate fresh MRS broth supplemented with 0.05%
(final concentration) cysteine-HCl and 16% (v/w)
fructo-oligosaccharides (FOS) (Actilight®; Beneo-Orafti),
a commercial product comprising a mix of short-chain
FOS (1-kestose, nystose, and fructosylnystose; FOS) or
10% galacto-oligosaccharides (GOS) (Sigma), and culti-
vated overnight at 37 °C under anaerobic conditions. This
overnight culture was diluted 1 : 10 in fresh MRS broth
supplemented with 16% FOS or 10% GOS and cultivated
at 37 °C until an OD600 nm of 0.6–0.7 was reached. Then,
bacteria were chilled on ice, harvested by centrifugation
(4500 r.p.m. for 15 min), and washed twice with washing
buffer composed of 1 mM citrate buffer supplemented
with 16% FOS or 10% GOS (pH 6.0). Finally, cells were
resuspended in about 1/250 of the original culture volume
of ice-cold washing buffer, dispensed in Eppendorf tubes
and incubated at 4 °C for 30 min to 3 h.
Electroporation
Plasmid DNA (200 ng) was mixed with 80 lL bacterial
suspension in a precooled Gene Pulser disposable cuvette
with an interelectrode distance of 0.2 cm (Eppendorf). A
high-voltage electric pulse was delivered employing a Gene
Pulser apparatus (BioRad, UK) using 25 lF capacity and a
parallel resistance of 200 O. Following electroporation,
bacteria were diluted with 920 lL cMRS broth. Bacteria
were incubated for 3 h at 37 °C in an anaerobic cabinet to
facilitate cell recovery and expression of the antibiotic resis-
tance marker, after which cells were plated on cMRS agar
supplemented with 3 lg mL1 chloramphenicol. Plates
were then incubated anaerobically at 37 °C for 48–72 h.
Selection of the transformants
Transformants were cultivated on cMRS supplemented with
chloramphenicol at a final concentration of 3 lg mL1.
Table 1. Bacterial strains and plasmids used in this study
Bacterial strains Reference
B. bifidum PRL2010 Turroni et al. (2010)
B. asteroides PRL2011 Unpublished data
Plasmids
Code Size (bp)
pNZ8048 3349 bp de Ruyter et al. (1996)
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DNA was extracted from colonies using GeneReleaser
(BioVentures), and the presence of pNZ8048 in transfor-
mants was confirmed by PCR using the primers pNZFw
(5′-TTTGCAGCGAAGATGTTGTC-3′) and pNZRv (5′-
CTATAGCTAACGCCGCAACC-3′) targeting DNA regions
on this plasmid. The transformation efficiency was
calculated according to the following formula:
E ¼ ½
P
c  ð1 10xÞ
ðDNAlgÞ
where Σ c is the total number of transformants and x is
the dilution factor applied.
Transformation experiments were performed in tripli-
cate.
Plasmid stability studies
Transformants were inoculated into fresh broth in the
presence of chloramphenicol and grown for 24 h. These
cultures were then screened for plasmid content prior to
the start of the experiment to ensure that plasmid
pNZ8048 was present. Cultures were then diluted (1%) in
fresh broth without chloramphenicol, followed by contin-
uous subcultivation for 15 days by dilution into fresh
broth every 24 h in the absence of antibiotic selection. To
determine plasmid stability, at least 50 colonies from each
tested transformant were transferred to cMRS agar plates
with or without chloramphenicol (3 lg mL1). Growth
of these colonies was monitored following 24 h of incu-
bation, and plasmid extractions were performed where
relevant.
Mouse colonization
All animals used in this study were cared for in compli-
ance with guidelines established by the Italian Ministry of
Health. All procedures were approved by the University
of Parma, as executed by the Institutional Animal Care
and Use Committee (Dipartimento per la Sanità Pubblica
Veterinaria, la Nutrizione e la Sicurezza degli Alimenti
Direzione Generale della Sanità Animale e del Farmaco
Veterinario). Two groups, each containing six animals of
3-month-old female BALB/c mice, were orally inoculated
with bacteria or with water. Bacterial colonization was
established by five consecutive daily administrations
whereby each animal received 20 lL of 109 mL1 of cells
using a micropipette tip placed immediately behind the
incisors (Sleator et al., 2001). Bifidobacterial inocula were
prepared by growing B. bifidum PRL2010 containing
pNZ8048 anaerobically overnight at 37 °C in cMRS broth
containing 3 lg mL1 chloramphenicol. Cultures were
harvested by centrifugation (950 g for 8 min), washed,
and resuspended in 100 lL of water. The viable count of
each inoculum was determined by retrospective plating
on cMRS containing the antibiotic. To estimate the num-
ber of B. bifidum PRL2010 cells per gram of feces, indi-
vidual fecal samples were weighed and followed by serial
dilution and culturing on selective cMRS agar with chl-
oramphenicol. Following enumeration of B. bifidum
PRL2010 in fecal samples, 100 random colonies were fur-
ther tested to verify their identity by the use of PCR
primers targeting the pil2 and pil3 loci (Foroni et al.,
2011).
Results and discussion
It has previously been reported that B. bifidum cells are
practically nontransformable (Argnani et al., 1996). To
corroborate such findings, we employed a previously
described transformation protocol for B. bifidum PRL
2010 (Turroni et al., 2010) and B. asteroides PRL2011
(F. Bottacini, F. Turroni, and M. Ventura, unpublished
data), which is highly effective for other bifidobacterial
strains, such as Bifidobacterium breve UCC2003 (O’Con-
nell Motherway et al., 2009). However, as displayed in
Table 2, no PRL2010 transformants were obtained using
this procedure. Thus, to genetically access B. bifidum
PRL2010 and B. asteroides PRL2011, for which the
genome sequences are currently available (F. Bottacini,
F. Turroni, and M. Ventura, unpublished data), an
efficient transformation protocol is required. Accordingly,
we assessed and varied various critical parameters of the
bacterial transformation protocol, such as preparation of












FOS OD value of 0.4 0
OD value of 0.7 1.3 9 103
GOS OD value of 0.4 0
OD value of 0.7 3.7 9 103
Resistances Voltages (kV cm1)




FOS 200 O 7.5 2.0 9 102
12.5 1.3 9 103
GOS 7.5 4.1 9 102
12.5 3.7 9 103
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electro-competent cells, electroporation buffers, and
electroporation conditions, which are discussed below.
Furthermore, susceptibility to the antibiotic used to select
transformants (chloramphenicol) was tested for both
B. bifidum PRL2010 and B. asteroides PRL2011 using the
MIC assays, which showed a resistance level below
0.5 lg mL1.
Preparation of electro-competent cells
The presence of a thick and multilayered cell wall in bac-
teria generally represents a barrier for the uptake of exog-
enous DNA molecules (Kullen & Klaenhammer, 2000).
Bifidobacteria possess a very thick and complex cell wall
(Fischer et al., 1987). In particular, for the B. bifidum
taxon, the peptidoglycan structure differs from that of
other bifidobacteria by the existence of specific cross-
linking dipeptide bond between the 5-amino group of
ornithine and the carboxyl group of C-terminal D-alanine
(Veerkamp & van Schaik, 1974). Thus, we attempted to
adapt our methodology so as to overcome this physical
barrier by varying several parameters such as (1) cultiva-
tion of bifidobacteria/transformants in the presence of
high concentration of complex carbohydrates; (2) the use
of bacterial cells collected at the exponentially growth
phase; (3) osmotic stabilizers in washing and electropora-
tion buffers; and (4) maintenance of cells at low tempera-
tures during all steps of the transformation procedure.
Growth media
The addition of carbohydrates at high concentration to
the growth medium is a strategy previously described to
be effective for transformation of other bifidobacterial
species such as Bifidobacterium animalis, Bifidobacterium
longum subsp. infantis, and Bifidobacterium longum subsp.
longum (Argnani et al., 1996; Rossi et al., 1996; Gugliel-
metti et al., 2007, 2008). In fact, the presence of a high
concentration of carbohydrates in the growth medium
and in the electroporation buffer has proven to be essen-
tial, as no transformants were observed when bacteria
were cultivated in the absence of an osmotic stabilizer
(Argnani et al., 1996). A similar strategy was followed
also for the preparation of the electro-competent B. bifi-
dum PRL2010 cells, which were cultivated in the presence
of different complex carbohydrates such as FOS or GOS.
Interestingly, PRL2010 transformants were isolated
when cells were grown in MRS supplemented with FOS
at a final content of 16% as well as with MRS enriched
by 10% GOS with a transformation efficiency of
103 CFU lg1 DNA (Table 2). Such findings may be
explained by the effects that these oligosaccharides have
on the composition of the cell wall as well as on other
cell envelope constituents (e.g. decreased thickness of cap-
sular polysaccharide layers and/or reduction of the cell
wall/capsular complexity). Furthermore, the presence of a
high amount of complex carbohydrates in the growth
medium may exert a protective action against the stressful
conditions encountered by bifidobacterial cells during
transformation (Guglielmetti et al., 2008).
Growth phase
Previous studies have reported that the composition of
the bacterial cell wall, and consequently the efficiency of
DNA uptake, seems to be significantly influenced by the
growth phase of the bacterial cells (Rossi et al., 1996).
Thus, based on the growth curve of B. bifidum PRL2010
cells cultivated on MRS, we harvested PRL2010 cells at
different time points corresponding to early (OD value of
0.4) and late exponential phase (OD value of 0.7)
(Fig. 1). Subsequently, such cells were submitted to the
electroporation procedure, and corresponding transfor-
mation efficiency was evaluated (Table 2). Notably, the
maximal transformation efficiency was observed when
PRL2010 cells were collected at late log phase (Table 2).
Electroporation buffers
Incubation of the cells in an electroporation buffer was
found to be crucial for Bifidobacterium transformation
(Argnani et al., 1996). We observed that storage of bacte-
rial cells for two hours before electroporation at 4 °C in
an electroporation buffer composed of 16% FOS or 10%
GOS and 1 mM citrate buffer (pH 6.0) significantly
improved their transformation efficiency, increasing from
< 102 to 104 CFU per lg DNA. Under these conditions,
we assume that the low molarity of ammonium citrate
acts as an osmotic stabilizer that supports controlled cell
envelope removal/degradation without affecting cell via-
bility, which may then result in improved cell wall per-
meability for exogenous DNA.
Electroporation condition and identification of
PRL2010 transformants
Resistances of 100 or 200 O and voltages between 7.5 and
12.5 kV cm1 were tested. Optimal results were obtained
when the voltage applied to the cuvette was 12.5 kV
cm1 and the resistance was set at 200 O. When the
resistance was set at 100 O, no transformants was
observed. The transformation efficiency achieved with a
voltage of 7.5 kV cm1 and a resistance of 200 O was
low (Table 2). After incubation, the transformants were
selected on MRS supplemented with chloramphenicol and
incubated at 37 °C. The presumptive transformants were
FEMS Microbiol Lett 333 (2012) 146–152 ª 2012 Federation of European Microbiological Societies
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verified by colony PCR using primers based on the DNA
sequence of pNZ8048. The transformation efficiency was
calculated to be 1.35 9 103 CFU per lg DNA when the
strain was grown in FOS, and 3.7 9 103 CFU per lg
DNA when grown in GOS (Table 2).
Plasmid stability was evaluated by continuous cultiva-
tion for 15 days of five PRL2010 transformants in the
absence of chloramphenicol selection by PCR assays.
Notably, all PRL2010 transformants tested did not exhibit
any plasmid loss during this period, despite the absence
of antibiotic selection.
Transformation of B. asteroides
To evaluate the general usefulness of the transformation
protocol developed here, we decided to apply it to
another Bifidobacterium species, B. asteroides PRL2011,
whose genome was recently decoded (F. Bottacini, F.
Turroni and M. Ventura, unpublished data). Interestingly,
the B. asteroides species represents a distantly related
taxon with respect to B. bifidum, while it also occupies a
different ecological niche, that is, the hindgut of honeybee
(Veerkamp & van Schaik, 1974; Fischer et al., 1987;
Argnani et al., 1996; de Ruyter et al., 1996; Hartke et al.,
1996; Rossi et al., 1996; Kullen & Klaenhammer, 2000;
Sleator et al., 2001; Schell et al., 2002; Ventura et al.,
2006, 2007, 2009; Guglielmetti et al., 2007, 2008; Sela
et al., 2008; O’Connell Motherway et al., 2009; Turroni
et al., 2010, 2011; Foroni et al., 2011; Serafini et al.,
2011). Thus, one may argue that the B. asteroides species
possesses a different cell envelope composition (e.g. exo-
polysaccharides, extracellular proteins) compared to that
of B. bifidum. When the transformation protocol
optimized on B. bifidum PRL2010 cells was employed for
transforming B. asteroides PRL2011 using pNZ8048, a
higher transformation efficiency (1.6 9 104 CFU per lg
DNA) was obtained as compared to B. bifidum PRL2010.
Bifidobacterium bifidum PRL2010 in
colonization in vivo experiments
A direct application from the results of the successful
transformation protocol described in this study was to
monitor the colonization efficiency of B. bifidum
PRL2010 in a murine model. In fact, so far, it has been
proven impossible to generate stable antibiotic-resistant
B. bifidum PRL2010 derivatives by spontaneous mutation
such as those in other bacterial species might be obtained
upon repeated cultivation in the presence of antibiotics.
Thus, to discriminate the presence of PRL2010 cells from
other members of the gut microbiota of mice, we
employed a derivative PRL2010 strain that contained a
plasmid carrying an antibiotic resistance gene to act as
a selective marker.
The normal microbiota of mice encompasses microor-
ganisms that are sensitive to chloramphenicol (Savino
et al., 2011), thus indicating that this antibiotic can be
used in selective media. Colonization and clearance of
PRL2010 were monitored over a 15-day period by deter-
mining viable counts recovered from fecal samples. Two
groups of six mice were fed orally on a daily basis with
either PRL2010 containing pNZ8048 (designated here as
PRL2010pNZ8048) or water for 1 week. In addition, 5%
(w/v) FOS was orally administered to the mice, in water
suspension, throughout the experiment to further
facilitate Bifidobacterium colonization. After 1 week, the
PRL2010pNZ8048 supplementation was discontinued, and
after one additional week, the animals were killed.
To follow PRL2010pNZ8048 colonization, fecal samples
were collected periodically (on days 0, 2, 5, 9, 12, and
15), and PRL2010pNZ8048 cell enumeration was performed
by plating fecal material on MRS–Cys–Agar supplemented
with chloramphenicol. After incubation at 37 °C, the
identity of colonies grown on MRS supplemented with
chloramphenicol was further evaluated using PCR and
employing PRL2010-specific primers that target pili-
encoding loci, which have been described previously
(Turroni et al., 2010; Foroni et al., 2011). The inoculated
bacterial population increased in number (Fig. 2), reach-
ing a maximum of 107 CFU g1 feces at day 5.
Interestingly, following this rapid increase of PRL2010
cell numbers during the period of bacterial supplementa-
tion, the level of PRL2010 cells decreased to reach a pla-
teau of approximately 105 CFU that appeared to remain
stable during the full length of the post-treatment period
(Fig. 2). Notably, the presence of high numbers of
PRL2010pNZ8048 cells upon a period of 7 days without
any supplementation with bifidobacterial cells reinforces
the notion that the plasmid is stable. Altogether these
data indicate that PRL2010 is capable of colonizing the

















Fig. 1. Growth curves of Bifidobacterium bifidum PRL2010 (10%) in
a growth medium containing different carbohydrates as carbon
sources. Times of cell collection corresponded to early (OD value of
0.4) and late exponential phase (OD value of 0.7).
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exploration of host–microbe interactions of this microor-
ganism using an in vivo murine model (O’Connell Moth-
erway et al., 2011).
Conclusion
This study describes an optimized protocol for the trans-
formation of bifidobacteria that enables the establishment
of plasmid DNA into two very distantly related species,
that is, B. bifidum and B. asteroides taxa, where in the lat-
ter case it represents the first report on plasmid-mediated
transformability. The transformation rates achieved were
sufficiently high for cloning purposes; nonetheless, the
experiments so far performed highlighted transformation
efficiency of 104 CFU lg1 which is not yet high enough
for site-directed mutagenesis and for an effective selection
of transformants in gene knock-out experiments (O’Con-
nell Motherway et al., 2009). The next step will be to
improve the transformation efficiency, which could be
achieved by overcoming the restriction modification sys-
tems of this microorganism (O’Connell Motherway et al.,
2009). Genetic tools to manipulate bifidobacteria are still
largely undeveloped and represent a bottleneck in the
advancing of knowledge on this important group of
microorganisms. Thus, the transformation protocol and
subsequent colonization model described in this study
offer two important adjuncts in exploring genomic func-
tionalities of bifidobacteria under in vitro as well as
in vivo conditions.
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